biospecimen_aliquot__bcr_aliquot_barcode	tcga-aq-a0y5-01a-11d-a14k-09
biospecimen_aliquot__bcr_aliquot_uuid	4aa80fbd-a337-49b6-9371-223cbcfbc85d
biospecimen_aliquot__bcr_patient_uuid	d0b78f3f-a198-437a-ab8c-204345d3b75d
biospecimen_aliquot__bcr_sample_barcode	tcga-aq-a0y5-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0108476643
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-04-26
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	4
biospecimen_aliquot__plate_id	a14k
biospecimen_aliquot__plate_row	h
biospecimen_aliquot__quantity	4.27
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	53.40
biospecimen_analyte__a260_a280_ratio	1.85
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-aq-a0y5-01a-11d
biospecimen_analyte__bcr_analyte_uuid	6e4514ff-4836-400f-83c8-3870d6ff76ec
biospecimen_analyte__bcr_patient_uuid	d0b78f3f-a198-437a-ab8c-204345d3b75d
biospecimen_analyte__bcr_sample_barcode	tcga-aq-a0y5-01a
biospecimen_analyte__concentration	0.15
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-aq-a0y5
biospecimen_diagnostic_slides__bcr_patient_uuid	d0b78f3f-a198-437a-ab8c-204345d3b75d
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-aq-a0y5-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	f68f5b49-30fa-4fb6-bec6-5da9f6809d02
biospecimen_normal_control__bcr_patient_barcode	tcga-aq-a0y5
biospecimen_normal_control__bcr_patient_uuid	d0b78f3f-a198-437a-ab8c-204345d3b75d
biospecimen_portion__bcr_patient_uuid	d0b78f3f-a198-437a-ab8c-204345d3b75d
biospecimen_portion__bcr_portion_barcode	tcga-aq-a0y5-01a-11
biospecimen_portion__bcr_portion_uuid	e1c8d2c8-94bb-46bd-8310-f738ac0303ee
biospecimen_portion__bcr_sample_barcode	tcga-aq-a0y5-01a
biospecimen_portion__date_of_creation	2011-01-19
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-aq-a0y5-01a-11d
biospecimen_protocol__bcr_patient_uuid	d0b78f3f-a198-437a-ab8c-204345d3b75d
biospecimen_protocol__bcr_sample_barcode	tcga-aq-a0y5-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	d0b78f3f-a198-437a-ab8c-204345d3b75d
biospecimen_sample__bcr_sample_barcode	tcga-aq-a0y5-01a
biospecimen_sample__bcr_sample_uuid	f5675b71-ed1b-4fdb-be07-d627dc98ed88
biospecimen_sample__days_to_collection	212
biospecimen_sample__initial_weight	160
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-aq-a0y5.5bc01981-366e-44ec-a986-087db7904e5c.pdf
biospecimen_sample__pathology_report_uuid	5bc01981-366e-44ec-a986-087db7904e5c
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_slide__bcr_patient_uuid	d0b78f3f-a198-437a-ab8c-204345d3b75d
biospecimen_slide__bcr_sample_barcode	tcga-aq-a0y5-01a
biospecimen_slide__bcr_slide_barcode	tcga-aq-a0y5-01a-01-msa
biospecimen_slide__bcr_slide_uuid	e8612b52-6969-4d03-aa70-0f11fb2de46f
biospecimen_slide__image_file_name	tcga-aq-a0y5-01a-01-msa.e8612b52-6969-4d03-aa70-0f11fb2de46f.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	84
biospecimen_slide__percent_tumor_cells	15
biospecimen_slide__percent_tumor_nuclei	15
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-aq-a0y5
biospecimen_tumor_sample__bcr_patient_uuid	d0b78f3f-a198-437a-ab8c-204345d3b75d
clinical_drug__bcr_drug_barcode	tcga-aq-a0y5-d10118
clinical_drug__bcr_drug_uuid	5c09333c-d15e-4c62-ad09-c1984b22cbda
clinical_drug__bcr_patient_barcode	tcga-aq-a0y5
clinical_drug__bcr_patient_uuid	d0b78f3f-a198-437a-ab8c-204345d3b75d
clinical_drug__form_completion_date	2011-4-7
clinical_drug__pharma_adjuvant_cycles_count	4
clinical_drug__pharmaceutical_therapy_drug_name	herceptin
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg/kg
clinical_drug__pharmaceutical_tx_ended_days_to	146
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	83
clinical_drug__pharmaceutical_tx_total_dose_units	mg/kg
clinical_drug__prescribed_dose	8
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	32
clinical_follow_up__bcr_followup_barcode	tcga-aq-a0y5-f10119
clinical_follow_up__bcr_followup_uuid	7cb4c161-65d3-44e6-82f7-cdaa2c40d530
clinical_follow_up__bcr_patient_barcode	tcga-aq-a0y5
clinical_follow_up__bcr_patient_uuid	d0b78f3f-a198-437a-ab8c-204345d3b75d
clinical_follow_up__death_days_to	172
clinical_follow_up__form_completion_date	2011-4-7
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	dead
clinical_omf__bcr_omf_barcode	tcga-aq-a0y5-o10120
clinical_omf__bcr_omf_uuid	4a7d3f10-39f9-46fc-9ca5-8e8975f0fe52
clinical_omf__bcr_patient_barcode	tcga-aq-a0y5
clinical_omf__bcr_patient_uuid	d0b78f3f-a198-437a-ab8c-204345d3b75d
clinical_omf__drug_tx_indicator	no
clinical_omf__form_completion_date	2011-4-7
clinical_omf__malignancy_type	prior malignancy
clinical_omf__other_malignancy_anatomic_site	bone marrow
clinical_omf__other_malignancy_histological_type	other, specify
clinical_omf__other_malignancy_histological_type_text	myelodysplastic syndrome
clinical_omf__radiation_tx_indicator	no
clinical_patient__age_at_diagnosis	70
clinical_patient__ajcc_metastasis_pathologic_pm	mx
clinical_patient__ajcc_nodes_pathologic_pn	n2a
clinical_patient__ajcc_pathologic_tumor_stage	stage iiia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	right
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-aq-a0y5
clinical_patient__bcr_patient_uuid	d0b78f3f-a198-437a-ab8c-204345d3b75d
clinical_patient__birth_days_to	-25793
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__death_days_to	172
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	70-79%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-4-7
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	3.8
clinical_patient__her2_fish_status	positive
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	positive
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	yes
clinical_patient__history_other_malignancy	yes
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2010
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	17
clinical_patient__lymph_nodes_examined_he_count	5
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a0y5
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	40-49%
clinical_patient__prospective_collection	yes
clinical_patient__race	white
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	aq
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	dead
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AQ-A0Y5-01A-11D-A14K-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AQ-A0Y5-01A-11D-A14K-09.bed.meta
manually_curated__id	tcga-aq-a0y5-01a-11d-a14k-09
manually_curated__md5sum	590c2ac8bad451a9496e5b8d602e4937
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	4aa80fbd-a337-49b6-9371-223cbcfbc85d
manually_curated__tumor_tag	brca
